The phenotypical analysis of slanMo in lesional AD skin samples identified these cells as a HLA-DR+ cell population lacking expression of the Langerhans cell marker CD1a, the monocyte/DC marker CD14 and the macrophage marker CD163 (Figure 1C). Here, CD163 is linked to Alzheimer disease.